Clinical Trials in Boston

Showing 6221-6240 of 17,836 trials

Pembrolizumab and Reirradiation in Bevacizumab Naïve and Bevacizumab Resistant Recurrent Glioblastoma

NCT03661723

This research study is studying pembrolizumab and re-irradiation as possible treatments for glioblastoma. The drugs involved in this study are: * Pembrolizumab * Radiation * Bevacizumab, an FDA-approved drug for treating recurrent glioblastoma multiforme (GBM)

Glioblastoma

Dana-Farber Cancer Institute60 participantsStarted Sep 2018

Boston, Massachusetts, United States • Boston, Massachusetts, United States • Boston, Massachusetts, United States +2 more locations

RECRUITING< 1 mile

Manual Versus AI-Assisted Clinical Trial Screening Using Large-Language Models

NCT06588452

A prospective randomized controlled trial comparing manual review and AI screening for patient eligibility determination and enrollments. A structured query will identify potentially eligible patients from the Mass General Brigham Electronic Data Warehouse (EDW), who will then be randomized into either the manual review arm or the AI-assisted review arm.

Comparing Manual and AI Patient Screening in Heart Failure

Brigham and Women's Hospital4,500 participantsStarted Mar 2024

Boston, Massachusetts, United States

Pembrolizumab and Reirradiation in Bevacizumab Naïve and Bevacizumab Resistant Recurrent Glioblastoma

Manual Versus AI-Assisted Clinical Trial Screening Using Large-Language Models

Find Trials by Condition in Boston

Study of DCR-PHXC-101 in Normal Healthy Volunteers and Patients With Primary Hyperoxaluria

Efficacy and Safety of MK-1942 When Added to Stable Antidepressant Therapy in Participants With Treatment-Resistant Depression (TRD) (MK-1942-006)

A Proof-of-concept RCT of Version 3.0 of the Smoking Cessation Smartphone App "Smiling Instead of Smoking" (SiS)

Strategies to Assist With Management of Pain

Phase 1, First-in-human Study of Oral TP-1287 in Patients with Advanced Solid Tumors

Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Neurotrophic Keratitis Subjects

Bridging the Gap From Postpartum to Primary Care

Clinical Evaluation of the i-STAT TBI Test

VTX958 Versus Placebo for the Treatment of Moderate to Severe Psoriasis

A Study to Evaluate Treatment Satisfaction With Erenumab in Participants With Migraine

Open-label Extension Study in Patients 65 Years or Older With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Nanoscope Cost Analysis Study

Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA

Pharmacokinetics and Pharmacodynamics of Rifaximin Novel Formulations in Patients With Sickle Cell Disease

Umbilical Cord Milking in Non-Vigorous Infants

Study of AZD9291 Plus MEDI4736 Versus AZD9291 Monotherapy in NSCLC After Previous EGFR TKI Therapy in T790M Mutation Positive Tumours

Acupuncture for Preterm Infants Requiring Eye-exam

Music Therapy Songwriting and Mental Health in Neonatel Intensive Care Unit (NICU) Parents